In this article, we describe the survival of patients with metastatic renal cell carcinoma (mRCC), initially managed with surgical removal of metastasis or metastasectomy (MxT). Over a period of time ranging from 1989 to 2015, patients presenting with metastasis thought to be amenable to complete resection and no evidence of disease (NED) status, fit enough to undergo surgery were considered primarily for MxT. A total of 138 patients were included, of which 127 (92%) reached NED status. No patient was International Metastatic RCC Database Consortium (IMDC) poor risk and interestingly, chronology, synchronous metastasis or not, as well as disease free interval between primary tumor removal and MxT of less than one year, had no impact on survival. Median overall survival (OS) and cancer specific survival (CSS) were 88 and 93 months respectively. Except for lung-only metastasis, location of metastasis had no impact on OS.